Sun Park - AmerisourceBergen President
| ABCDelisted Stock | USD 179.98 0.95 0.53% |
President
Mr. Sun Park is an Executive Vice President Strategy and Development of the Company., since May 2016. He served as Senior Vice President, Business Development from November 2012 to May 2016. Prior to joining the Company, Mr. Park served in various leadership roles at MedImmune and AstraZeneca, and held positions at Charterhouse Group International and Merrill Lynch Company. since 2016.
| Age | 40 |
| Tenure | 8 years |
| Phone | 610 727 7000 |
| Web | https://www.amerisourcebergen.com |
AmerisourceBergen Management Efficiency
The company has Return on Asset of 0.027 % which means that on every $100 spent on assets, it made $0.027 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 2.3366 %, implying that it generated $2.3366 on every 100 dollars invested. AmerisourceBergen's management efficiency ratios could be used to measure how well AmerisourceBergen manages its routine affairs as well as how well it operates its assets and liabilities.The company has 5.7 B in debt. AmerisourceBergen has a current ratio of 0.89, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Debt can assist AmerisourceBergen until it has trouble settling it off, either with new capital or with free cash flow. So, AmerisourceBergen's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like AmerisourceBergen sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for AmerisourceBergen to invest in growth at high rates of return. When we think about AmerisourceBergen's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Jonathan Leon | Owens Minor | 57 | |
| Lori Schechter | McKesson | 58 | |
| Lisa Capodici | Cardinal Health | N/A | |
| Les Korsh | Patterson Companies | 54 | |
| Stephen Falk | Cardinal Health | 49 | |
| Erin Lampert | McKesson | N/A | |
| Paul Rose | Henry Schein | 59 | |
| Mark Zacur | Owens Minor | 57 | |
| John Wright | Patterson Companies | N/A | |
| Joseph Pekala | Owens Minor | 47 | |
| Kevin Pohlman | Patterson Companies | 61 | |
| George Henriques | Patterson Companies | 64 | |
| Paul Julian | McKesson | 61 | |
| Rick Luckenbill | Zynex Inc | N/A | |
| Jay Romans | Owens Minor | 66 | |
| Sean Muniz | Patterson Companies | 46 | |
| Michael Racioppi | Henry Schein | 63 | |
| DTodd Healy | Owens Minor | 51 | |
| Andrew Long | Owens Minor | 59 | |
| Lorelei McGlynn | Henry Schein | 54 | |
| Christopher Lowery | Owens Minor | 57 | |
Management Performance
| Return On Equity | 2.34 | |||
| Return On Asset | 0.027 |
AmerisourceBergen Leadership Team
Elected by the shareholders, the AmerisourceBergen's board of directors comprises two types of representatives: AmerisourceBergen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AmerisourceBergen. The board's role is to monitor AmerisourceBergen's management team and ensure that shareholders' interests are well served. AmerisourceBergen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AmerisourceBergen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| James Frary, Executive VP and President of AmerisourceBergen Speciality Group | ||
| PharmD Mauch, Ex COO | ||
| James Cleary, Executive Vice President and Presidentident - MWI Veterinary Supply | ||
| Lonie Haynes, Senior Vice President Chief Diversity and Inclusion Officer | ||
| Dale Danilewitz, Executive Vice President, Chief Information Officer | ||
| Bennett Murphy, Vice President Investor Relations | ||
| Peyton HowellKoren, Executive Vice President AmerisourceBergen Corporation, and President Global Sourcing & Manufacturer Relations | ||
| Mark Durcan, Independent Director | ||
| John Chou, Executive Vice President, Chief Legal Officer and Secretary | ||
| Barbara Brungess, Vice President Corporate & Investor Relations | ||
| Dennis Nally, Independent Director | ||
| Elizabeth Campbell, Senior Vice President and Deputy General Counsel | ||
| Silvana Battaglia, Chief Human Resource Officer, Executive Vice President | ||
| Leslie Donato, Executive Vice President and Chief Strategy Officer | ||
| Lazarus Krikorian, Senior Vice President Principal Accounting Officer, Corporate Controller | ||
| Lawrence Marsh, Executive Vice President - New Market Development, Chief Strategy Officer | ||
| Henry McGee, Independent Director | ||
| Michael Long, Independent Director | ||
| Steven Collis, CEO and President Director and Member of Executive Committee | ||
| Robert Mauch, Executive Vice President, Group President - Pharmaceutical Distribution & Strategic Global Sourcing | ||
| Keri Mattox, Vice President - Corporate & Investor Relations | ||
| Sun Park, Executive Vice President - Strategy and Development | ||
| Ornella Barra, Director | ||
| Richard Gochnauer, Independent Director | ||
| Tim Guttman, CFO and Executive VP | ||
| Peyton Howell, Senior Vice President and Presidentident - Global Sourcing and Manufacturer Relations | ||
| Lon Greenberg, Independent Director | ||
| Gina Clark, Executive Vice President, Chief Communications & Administration Officer | ||
| D Durcan, Independent Director | ||
| David Neu, Executive VP of Retail Strategy and President of Good Neighbor Pharmacy | ||
| Douglas Conant, Independent Director | ||
| Kathleen Hyle, Independent Director | ||
| Kathy Gaddes, Chief Human Resource Officer, Executive Vice President | ||
| Jane Henney, Lead Independent Director | ||
| Richard Gozon, Independent Chairman of the Board | ||
| June Barry, Senior Vice President - Human Resources |
AmerisourceBergen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AmerisourceBergen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 2.34 | |||
| Return On Asset | 0.027 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | 41.48 B | |||
| Shares Outstanding | 200.85 M | |||
| Shares Owned By Insiders | 16.68 % | |||
| Shares Owned By Institutions | 78.91 % | |||
| Number Of Shares Shorted | 7.02 M | |||
| Price To Earning | 20.86 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards AmerisourceBergen in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, AmerisourceBergen's short interest history, or implied volatility extrapolated from AmerisourceBergen options trading.
Pair Trading with AmerisourceBergen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AmerisourceBergen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AmerisourceBergen will appreciate offsetting losses from the drop in the long position's value.Moving against AmerisourceBergen Stock
| 0.63 | CSCO | Cisco Systems Fiscal Quarter End 30th of April 2024 | PairCorr |
The ability to find closely correlated positions to AmerisourceBergen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AmerisourceBergen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AmerisourceBergen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AmerisourceBergen to buy it.
The correlation of AmerisourceBergen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AmerisourceBergen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AmerisourceBergen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AmerisourceBergen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the AmerisourceBergen information on this page should be used as a complementary analysis to other AmerisourceBergen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Consideration for investing in AmerisourceBergen Stock
If you are still planning to invest in AmerisourceBergen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AmerisourceBergen's history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Stocks Directory Find actively traded stocks across global markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |